Evaluation and Management of Purpura in a 78-Year-Old Woman

Immediately obtain a complete blood count with platelet count and peripheral blood smear to differentiate between thrombocytopenic and non-thrombocytopenic purpura, as this single distinction determines all subsequent management decisions.

Initial Diagnostic Approach

The evaluation must rapidly distinguish between two fundamentally different categories:

1. If Platelet Count is Low (<100 × 10⁹/L)

This suggests immune thrombocytopenic purpura (ITP) or other thrombocytopenic disorders. The diagnostic workup should include 1, 2:

Complete blood count with reticulocyte count - to confirm isolated thrombocytopenia
Peripheral blood smear - to exclude pseudothrombocytopenia and identify schistocytes (which would suggest TTP)
Quantitative immunoglobulin levels - to screen for immunodeficiency
HIV, HCV testing - secondary causes in adults
Antinuclear antibodies - to exclude lupus-associated thrombocytopenia

Tests to avoid as they lack clinical utility 3:

Platelet-associated IgG assay (inappropriate)
Platelet antigen-specific antibody assay (unnecessary)
Platelet survival studies (unnecessary)
Bone marrow biopsy (not routinely needed in typical presentations)

2. If Platelet Count is Normal

Consider non-thrombocytopenic purpura, which in a 78-year-old woman most commonly includes:

Senile (actinic) purpura - chronic sun damage causing vascular fragility, typically on dorsal hands and forearms 4
Medication-induced purpura - anticoagulants, antiplatelet agents, corticosteroids
IgA vasculitis (Henoch-Schönlein purpura) - rare in elderly but can occur with multisystem involvement 5, 6, 7
ANCA-associated vasculitis - particularly if necrotizing ulcers present 8

For suspected vasculitis, obtain 9:

Skin biopsy with direct immunofluorescence - essential to differentiate IgA vasculitis from pauci-immune vasculitis
ANCA testing (c-ANCA/PR3, p-ANCA/MPO) - if systemic symptoms present
Urinalysis - to detect renal involvement
Complement levels (C3, C4) - if systemic lupus suspected

Management Based on Platelet Count

For ITP (Thrombocytopenic Purpura)

Platelet Count <20 × 10⁹/L

Treatment is mandatory regardless of symptoms 3, 1:

Prednisone 1-2 mg/kg/day is the appropriate initial treatment 3
Hospital admission should be considered for newly diagnosed cases, particularly with platelet counts <20 × 10⁹/L 1
IVIg is reserved only for severe, life-threatening bleeding (not routine first-line) 3

Platelet Count 20-30 × 10⁹/L

Corticosteroids are appropriate even if asymptomatic 3
Outpatient management acceptable if established diagnosis and no active bleeding 1

Platelet Count 30-50 × 10⁹/L

Treat only if clinically important bleeding present 3
Observation is appropriate if asymptomatic or minor purpura only

Platelet Count ≥50 × 10⁹/L

Observation recommended unless significant mucous membrane bleeding 1
Treatment generally not indicated

Life-Threatening Bleeding (Any Platelet Count)

Aggressive multi-modal therapy 3:

High-dose corticosteroids (methylprednisolone 30 mg/kg/day IV)
IVIg (appropriate in this setting)
Platelet transfusion
Consider hospitalization in ICU setting

Critical monitoring for elderly patients on corticosteroids 3, 1:

Hyperglycemia (especially relevant given age)
Hypertension
Osteoporosis risk (major concern in 78-year-old)
Gastric ulceration
Mental status changes

For Non-Thrombocytopenic Purpura

Senile Purpura

No specific treatment required 4
Reassurance and patient education
Review medications that may worsen bleeding (anticoagulants, antiplatelets, chronic corticosteroids)
Protective measures to avoid trauma
If oral manifestations present with dentures, ensure proper fit to prevent trauma-induced bleeding

IgA Vasculitis (HSP) in Elderly

This is a serious diagnosis in elderly patients with worse prognosis than in children 5, 6, 7:

Pulse methylprednisolone followed by oral corticosteroids for systemic involvement 5
Cyclophosphamide may be needed for severe renal or pulmonary involvement 5
Monitor for:
- Renal failure (common in elderly HSP)
- Gastrointestinal bleeding/intussusception (rare but reported)
- Cardiac involvement (extremely rare but life-threatening) 6

ANCA-Associated Vasculitis (if necrotizing features)

Pulse methylprednisolone + cyclophosphamide for induction 8
This is critical if DIF is negative for IgA and ANCA is positive

Key Clinical Pitfalls

Do not assume senile purpura without checking platelet count - ITP can present at any age
Do not perform bone marrow biopsy routinely - it adds no diagnostic value in typical ITP presentations 2
Do not use platelet-associated IgG testing - it is inappropriate and unhelpful 3
Do not miss vasculitis - if purpura is palpable, painful, or associated with systemic symptoms, perform skin biopsy with DIF 9, 8
In elderly patients with "HSP," always obtain ANCA testing and DIF - GPA can mimic IgA vasculitis and requires different treatment 8
Monitor elderly patients on corticosteroids aggressively - osteoporosis and hyperglycemia are major concerns in this age group 3, 1

Algorithmic Summary

Purpura in 78-year-old woman
         ↓
    CBC with platelet count
         ↓
    ┌────────────────┴────────────────┐
    ↓                                  ↓
Platelets <100 × 10⁹/L          Platelets normal
(Suspect ITP)                    (Non-thrombocytopenic)
    ↓                                  ↓
Peripheral smear              Examine distribution
Rule out TTP                  and characteristics
    ↓                                  ↓
If <20: TREAT                 ┌───────┴────────┐
If 20-30: TREAT               ↓                ↓
If 30-50: Treat if bleeding   Dorsal hands/    Palpable/painful
If >50: Observe               forearms         + systemic symptoms
    ↓                         ↓                ↓
Prednisone 1-2 mg/kg/day     Senile purpura   Skin biopsy + DIF
Monitor closely              Reassure          + ANCA testing
                             Review meds       Treat vasculitis

How should purpura in a 78-year-old woman be evaluated and managed?

Have a follow-up question?